Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.515 USD | +2.51% | -0.02% | -3.94% |
22/03 | Sangamo Therapeutics Prices $24 Million Registered Direct Offering | MT |
14/03 | Sangamo Therapeutics Pushes Neurology Programs Toward Clinical Development, Wedbush Says | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.94% | 104M | |
+3.34% | 108B | |
+10.31% | 105B | |
+1.57% | 23.46B | |
-13.14% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-7.29% | 17.19B | |
+5.85% | 13.99B | |
+37.12% | 12.53B |
- Stock Market
- Equities
- SGMO Stock
- News Sangamo Therapeutics, Inc.
- Sangamo Therapeutics Says Early Phase 1/2 Data Shows 'Durable' Safety, Efficacy of Fabry Disease Drug Candidate